|Articles|February 19, 2016
Make the Pain Stop: New Shared Platform Eases Investigators’ Burden
Author(s)DIA
Advertisement
TransCelerate BioPharma Inc. CEO Dr. Dalvir Gill shares results of their recent collaboration with the Society for Clinical Research Sites: The Shared Investigator Platform designed to reduce administrative burden by enabling investigative sites to interact with multiple clinical trial sponsors through a single point of access.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
